Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: a phase IV study.

Özcan M., Cassaday R. D., Zarzycka E., Vandendries E., Zhang F., Chen Y., ...Daha Fazla

Haematologica, cilt.110, 2025 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 110
  • Basım Tarihi: 2025
  • Doi Numarası: 10.3324/haematol.2024.286091
  • Dergi Adı: Haematologica
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, Directory of Open Access Journals
  • Ankara Üniversitesi Adresli: Evet